Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Sreedhar Reddy Suthe | Researchclopedia

Back to researchers

Sreedhar Reddy Suthe

Texas Tech University

34

Works

172

Citations

8

h-index

6

i10-index

Research Topics

Cancer Research and Treatments HER2/EGFR in Cancer Research Nanoparticle-Based Drug Delivery

Affiliations

Texas Tech University2018–2025

Spencer Foundation2018–2018

Scientific Systems (United States)2023–2023

First Affiliated Hospital Zhejiang University2018–2022

Zhejiang University2018–2018

Top Works

RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE

Sreedhar Reddy Suthe,Hangping Yao,et al.

201827 citations

Monoclonal and Polyclonal Antibodies Research

Liver physiology and pathology

Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability

Yan Feng,Jaewon Lee,et al.

202326 citations

Preclinical Efficacy of Anti-RON Antibody–Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase

Hangping Yao,Liang Feng,et al.

201825 citations

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

Xiang-Min Tong,Liang Feng,et al.

201923 citations

Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

Hangping Yao,Liang Feng,et al.

201923 citations

Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

Hangping Yao,Liang Feng,et al.

201919 citations

Humanized dual-targeting antibody–drug conjugates specific to MET and RON receptors as a pharmaceutical strategy for the treatment of cancers exhibiting phenotypic heterogeneity

Ming‐Hai Wang,Qi Ma,et al.

20259 citations

Antibody–drug conjugates targeting RON receptor tyrosine kinase as a novel strategy for treatment of triple-negative breast cancer

Hangping Yao,Sreedhar Reddy Suthe,et al.

20209 citations

Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel TherapeuticEntity for Targeted Treatment of Cancers Aberrantly ExpressingMET Receptor Tyrosine Kinase

Rachel Hudson,Hangping Yao,et al.

20215 citations